Amicar and Sinusitis - a phase IV clinical study of FDA data

Summary:

Sinusitis is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 20-29 old, also take Synthroid, and have Abnormal dreams.

The phase IV clinical study analyzes which people have Sinusitis when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,399 drugs and 2,723 conditions by eHealthMe. Check the latest studies of Sinusitis.

On Jun, 20, 2026

1,317 people reported to have side effects when taking Amicar.
Among them, 11 people (0.84%) have Sinusitis.

Among these 11 people:

What is the gender of people who have Sinusitis when taking Amicar? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Sinusitis when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Sinusitis? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 63.64%
Cardiac Arrest: 7 people, 63.64%
Corneal Erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying): 7 people, 63.64%
Daydreaming: 7 people, 63.64%
Injury Corneal: 7 people, 63.64%
Nosebleed (bleeding from nose): 4 people, 36.36%
White Blood Cell Count Decreased: 1 person, 9.09%
Fatigue (feeling of tiredness): 1 person, 9.09%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 9.09%
Atelectasis (partial or complete collapse of the lung): 1 person, 9.09%

What are the existing conditions these people have? *

Sleep Walking (walking during sleep): 7 people, 63.64%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 63.64%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 63.64%
Abnormal Dreams: 7 people, 63.64%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 9.09%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 9.09%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Sinusitis?

- Check whether Sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Sinusitis treatments and more:

Sinusitis (153,484 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis:

Sinusitis (2,399 drugs)

Browse all the conditions that are associated with Sinusitis:

Sinusitis (2,723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.